top of page


Investigators of the CRISPR Cures for Cancer Initiative are conducting research at the intersection of genomic technologies and cellular immunotherapies at UC San Francisco, Gladstone Institutes, or the Innovative Genomics Institute at UC Berkeley. With our first RFP cycle in 2023, we added 12 new investigators to our network of researchers.

bottom of page